1 May 2012PatentsPablo Fuentes

A step forward: new dosage patents in Mexico?

In Mexico, as in most of the IP systems around the world, pharmaceutical patents can be obtained to protect novel drug molecules; intermediate compounds thereof; processes for manufacturing such molecules and intermediates; compositions containing them; and uses of the new molecules in a specific therapeutic way. Likewise, new pharmaceutical formulations, new methods of preparation, new crystalline forms, and new therapeutic uses of already known molecules are also available for protection.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

16 December 2021   The introduction of partial non-use cancellation actions in Mexico was welcome, but will they have the intended impact, asks Vanessa Rondeau of Uhthoff, Gómez Vega & Uhthoff.
Jurisdiction reports
30 September 2021   The last amendments to Mexico’s IP law were issued on May 18, 2018, and confirmed through the New Mexican IP Law of July 1, 2020, incorporate some new legal figures for trademark registrations based on use. In particular, article 173 of the new Federal Law for Protection of Industrial Property in Mexico states a list of non-registrable signs.